2BB score and signals
Candel Therapeutics, Inc.’s current 2BB score is 47 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 70 | High |
| Momentum | 62 | Improving |
| Financial strength | 15 | Very Weak |
| Quality | 80 | Very Strong |
| Risk | 43 | Moderate |
Company facts
| Headquarters | Needham, Massachusetts, United States |
| Founded | 2003 |
| Employees | 55 |
| 52-week range | $4.35 – $11.35 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-11 | — | -0.3548 | — | $0.00 |
| 2026-08-19 | — | -0.2414 | — | $0.00 |
| 2026-05-14 | -0.14 | -0.3232 | $0.00 | $0.00 |
| 2026-03-12 | -0.54 | -0.2508 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish